Joost J. Breeksema

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Psychedelica bij de behandeling van psychiatrische aandoeningen anno 2025

Psychedelica bij de behandeling van psychiatrische aandoeningen anno 2025

Journal: Tijdschrift voor psychiatrie

Published: August 11, 2025

Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.

Psychedelics for the treatment of end-of-life distress in patients with a life-threatening disease.

Journal: International review of neurobiology

Published: June 20, 2025

Post-traumatic stress disorder in psychedelic research.

Post-traumatic stress disorder in psychedelic research.

Journal: International review of neurobiology

Published: June 20, 2025

Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic review.

Ketamine-assisted psychotherapies for mental disorders: A historical overview and systematic review.

Journal: Clinical psychology review

Published: May 31, 2025

On Minimizing Risk and Harm in the Use of Psychedelics.

On Minimizing Risk and Harm in the Use of Psychedelics.

Journal: Psychiatric research and clinical practice

Published: October 18, 2024

Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.

Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.

Journal: The lancet. Psychiatry

Published: August 05, 2024

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.

Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.

Journal: Scientific reports

Published: August 24, 2023

Correction to: Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.

Correction to: Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.

Journal: Psychopharmacology

Published: June 17, 2023

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study.

Phenomenology and therapeutic potential of patient experiences during oral esketamine treatment for treatment-resistant depression: an interpretative phenomenological study.

Journal: Psychopharmacology

Published: March 13, 2023

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.

Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review.

Journal: Journal of psychopharmacology (Oxford, England)

Published: August 26, 2022

Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study.

Holding on or letting go? Patient experiences of control, context, and care in oral esketamine treatment for treatment-resistant depression: A qualitative study.

Journal: Frontiers in psychiatry

Published: May 19, 2022

Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.

Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.

Journal: Psychopharmacology

Published: July 08, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026